NCT00151983 - Safety & Tolerability of MTS in Children Aged 6-12 Diagnosed With ADHD & Previously Treated With Extended-Release Methylphenidate Therapy | Biotech Hunter

Enrollment

175

Participants

Timeline

Start Date

June 30, 2005

Primary Completion Date

July 31, 2006

Study Completion Date

July 31, 2006

Conditions

Attention Deficit Disorder With Hyperactivity

Interventions

DRUG

Methylphenidate Transdermal System

To assess the efficacy of 4- and 6-hour wear times of SPD485 (MTS) compared to placebo

Trial Locations (18)

Meadowbrook Research, Inc., Scottsdale

Psychiatric Centers at San Diego, San Marcos

Alpine Clinical Research Center, Boulder

Miami Research Associates, Inc., Miami

Capstone Clinical Research, Libertyville

Pedia Research, LLC, Owensboro

ProMed Pediatrics, Kalamazoo

Children's Specialized Hospital, Toms River

North Carolina Neuropsychiatry PA, Chapel Hill

Ohio State University, Columbus

IPS Research Company, Oklahoma City

Oregon Center for Clinical Investigations (OCCI, Inc.), Portland

CNS Research Institute, Philadelphia

Western Psychiatric Institute & Clinic, Pittsburgh

Claghorn-Lesem Research Clinic, Bellaire

ADHD Clinic of San Antonio, San Antonio

NeuroScience, Inc., Herndon

Monarch Medical Research, Norfolk